ASX share Opthea Limited (ASX: OPT) remains suspended from trading as the biotech company works to avoid insolvency. Opthea last traded at 60 cents per share. Last week,...
Image source: Getty Images What has happened on the stock markets this week, both here on the ASX and on international markets, might trigger some rather...
Image source: Getty Images The S&P/ASX 200 Index (ASX: XJO) plummeted by 191.9 points or 2.44% on Friday to finish the week at 7,667.8 points. Uncertainty...
Image source: Getty Images If you want to grow your wealth but feel unsure about picking individual shares — or you’re already heavily exposed to Australian...
Young African Businesswoman Analyzing Data On Multiple Computer Screen In Office Over the past few weeks, I’m sure many ASX investors have considered how to position...
Image source: Getty Images ASX biotech share Opthea Limited (ASX: OPT) remains frozen at 60 cents apiece following a failed Phase 3 clinical trial. In an update this...
Image source: Getty Images The ASX share market is being hit by a wave of investor selling as the market adjusts to what’s going on with...
Image source: Getty Images Investors looking for exposure to the growing field of respiratory healthcare and sleep apnoea treatment may find themselves comparing two ASX-listed giants:...
Image source: Getty Images The world is experiencing a rough start to April 2025 as investors react to the latest tariff news out of the US....
Image source: Getty Images If you are looking for ASX 200 stocks to buy in April after recent weakness, then it could be worth listening to...